Low cardiac output or shock or circulatory failure was the terminal state of any disease including cardiovascular problem. It is consist distributive, volume, obstructive and cardiogenic circulatory failure leading multi organ failure and mortality. Hemodynamic monitoring is important evaluation to guide the medication and treatment.
Educative power-point presentation for students in paediatrics, paediatric critical care, neonatology, And trainees or fellows in paediatric critical care
Fluid management and Fluid Responsiveness in ICCU / ICU at ASMIHA workshop 2018Isman Firdaus
It is very important for cardiologist or intensivist to determined fluid overload vs loss fluid. Misconception of hypervolemic and hypovolemic state was very important.
Angiografi koroner perkutan merupakan tindakan kateterisasi dengan menyemprotkan zat kontras ke dalam arteri koroner untuk melihat anatomi arteri koroner sehingga dapat mendeteksi ada atau tidaknya penyempitan (stenosis) yang dimonitor melalui sinar X
Isicam, high bleeding risk pci,2016,ismanIsman Firdaus
Presented by Dr. Isman Firdaus in ISICAM 2016
PCI in high bleeding risk patient was tricky management
Drug Coated Stent vs Bare Meta stent regarding LEADERS FREE trial.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. FACULTY
Instructor Qualification and Institution
Dr. Isman Firdaus, SpJP(K), FIHA, FAsCC, FAPSIC,
FESC, FSCAI
Cardiovascular Intensivist-Intervensionist
ICVCU Harapan Kita Hospital
Dr. Dafsah A Juzar, SpJP(K), FIHA, FAsCC, FAPSIC,
FESC
Cardiovascular Intensivist-Intervensionist
ICVCU Harapan Kita Hospital
Dr. Rita Zahara, SpJP(K), FIHA Cardiovascular Intensivist
ICU Post Cardiac Surgery Harapan Kita
Hospital
Dr. M. Fadhil, SpJP(K), FIHA Cardiovascular Intensivist-Intervensionist
RSUP M Djamil Padang
Dr. Siska Suridanda, SpJP(K), FIHA Cardiovascular Intensivist-Intervensionist
ICVCU Harapan Kita Hospital
Dr. Akhtar, SpJP(K), FIHA Cardiovascular Intensivist-Intervensionist
ICVCU RS Wahidin Makassar
3. The Objectives
1. Definition, pathophysiology and clinical diagnosis of LCO
2. Volemic, distributive, obstructive and cardiogenic shock
3. Hemodynamic assessment of LCO invasive and non
Invasively: Preload assessment, Afterload, Contractility
4. vasoactive drugs, such as vasopressor (noradrenaline,
adrenaline, and vasopressin)
5. Hemodynamic interpretation with simulation cases and
how to intervene
6. knowledge and Skill of CVC line insertion
7. Skills on hemodynamic assessment using non invasive
device
4. Time Topics Instructor
07.30 – 08.00 Re-registration
08.00 – 08.30 Opening Isman Firdaus, MD
Pretest All Instructors
08.30 – 09.00 Definition, and Clinical Diagnosis of LCO + Care Plane in ICVCU Isman Firdaus, MD
09.00 – 09.30 Introduction of Hemodynamic Monitoring Rita Zahara, MD
09.30 – 10.00 ABC of Acute Heart Failure M. Fadhil , MD
10.00 – 10.30 Coffee Break
10.30 – 11.15 Preload Assessment and Fluid Management in ICCU Dafsah A Juzar, MD
11.15 – 12.00 Cardiac Output and Afterload problem in ICCU: Non-Invasive and
Invasive Measurement
Isman Firdaus, MD
12.00 – 13.30 Lunch
13.30 – 14.00 Pressor vs Inotropic Support in Low Cardiac Output State: Tips and
Tricks
Retno Widowati, MD
14.00 – 14.30 Device in ICCU: Management and Complication Akhtar F Muzakkir, MD
14.30 – 15.00 Case discussion:
Cardiogenic Shock Case
Device Case
Preload Case
All Instructors
15.00 – 15.30 Post Test
Closing
All Instructors
Isman Firdaus, MD
Workshop on Acute Cardiovascular Care: Low Cardiac Output Management in ICCU
Day, date : Thursday, April 19, 2018
Venue : Mutiara 10, Ritz-Carlton Hotel, Jakarta
Time : 07.30 – 16.00
5. Definition and Clinical Diagnosis of Low Cardiac Output
(Volume, Distributif, Obstructive, and Cardiogenic)
Isman Firdaus, MD
FIHA, FAsCC, FAPSIC, FESC, FSCAI
Intensive Cardiovascular Care Unit, National Heart Center, Harapan Kita Hospital/
Departement of Cardiology and Vascular Medicine,
Faculty of Medicine, University of Indonesia
7. • Low cardiac output syndrome as the requirement
for MCS or inotropic support for longer than 30
minutes in intensive care unit to maintain the
systolic blood pressure higher than 90 mm Hg
and the cardiac index greater than 2.2 L/min per
square meter (Rao et all)
9. Cardiogenic Shock:
• Sindrom klinis yang disebabkan oleh gagal perfusi
akibat gangguan fungsi jantung yang ditandai
dengan nadi lemah, penurunan MAP < 65 mmHg,
penurunan cardiac index, terdapat peningkatan
LVEDP (LVEDP > 18 mmHg), dan penurunan curah
jantung (CO < 3,2 L/mnt)
• Syok kardiogenik dapat disebabkan oleh sindrom
koroner akut, masalah valvular, dan gagal jantung
yang berat, komplikasi mekanik ACS seperti
chordae rupture, IVS rupture, dan free wall
rupture.
10. Anamnesis
– Gangguan kesadaran mulai dari kondisi ringan hingga berat
– Penurunan diuresis
– Dapat disertai keringat dingin
– Nadi lemah
11. Pemeriksaan Fisik
– Terdapat tanda tanda hipoperfusi seperti perabaan kulit
ekstremitas dingin, takikardi, nadi lemah, hipotensi, bising
usus berkurang, oliguria
– Terdapat tanda-tanda peningkatan preload seperti JVP
meningkat atau terdapat ronki basah di basal
– Profil hemodinamik Forrester: basah dan dingin (wet and
cold)
12. Kriteria Diagnosis:
– Memenuhi kriteria anamnesis
– CO < 3,2 L/mnt atau CI < 2,2
– SVR meningkat pada fase awal, normal atau menurun pada
kondisi lanjut
– Pre load cukup atau meningkat
– TAPSE < 1,5 cm dari pemeriksaan ekokardiografi
– Diuresis < 0,5 mL/KgBB/jam
13. Target Tatalaksana
• Subjektif : tidak ada keluhan
• Objektif :
– MAP > 65 tanpa support inotropic atau MCS, atau TDS
>90 mmHg
– Diuresis > 1 cc/kg/jam
– CI > 2,2 atau CO > 3,5
– Residu –
CARE PLAN
14. Cardiac Output and Afterload
problem in ICCU: Non-Invasive and
Invasive Measurement
Isman Firdaus, MD
FIHA, FAsCC, FAPSIC, FESC, FSCAI
15. What Do You Need to Know When You
Resuscitate a Patient in Shock?
• Arterial blood pressure
• Urine output
• Systemic acid–base balance (pH, SBE, lactate)
• Clinical assessment of tissue perfusion
– “warm and well perfused” or “cold and shut down”
• Measurement of global blood flow and tissue
perfusion
– Cardiac output or cardiac index
• Arterial oxygen delivery, oxygen uptake index
• Mixed venous saturation and PvO2
16. Characteristics of circulatory shock
Complex clinical syndrome encompassing a group of
conditions with variable hemodynamic manifestations
Common denominator is generalised inadequacy of
blood flow through the body; hypoperfusion
compromises the delivery of oxygen and nutrients
and the removal of metabolites; tissue hypoxia shifts
metabolism to anaerobic pathways with production of
lactic acid
if shock is not corrected it leads to:
a) cell dysfunction
b) irreversible multiorgan insufficiency
d) death
Characteristics of circulatory shock
17. Etiology of circulatory shock
1. Hypovolemic - intravascular fluid volume loss
hemorrhage, fluid depletion or
sequestration
2. Cardiogenic - impairment of heart pump
myopathic lesions: myocardial
infarction, cardiomyopathies
dysrhythmias
obstructive and regurgitant lesions of
intracardial blood flow mechanics
18. 3. Obstructive - factors extrinsic to cardiac valves and
myocardium
v. cava obstruction, pericardial
tamponade,
pulmonary embolism,
coarctation of aorta
4. Distributive - pathologic redistribution of intravascular
fluid volume
septicaemia: endotoxic, secondary to
specific infection
anaphylactic
19. HYPOVOLEMIC
EXTRACARDIAC
Obstruction CARDIOGENIC DISTRIBUTIVE
Fluid loss,
hemorrhage
e.g., Pericardial
tamponade
Myocardial
injury or
necrosis
Decreased
systemic
vascular
resistance
Myocardiac
dysfunction
Reduced
systolic performance
Reduced
filling
Low cardiac
output
Reduced
preload
Decreased arterial
pressure
Shock
Multiple organ
system failure
High or normal
cardiac output
Maldistribution
of blood flow in
microcirculation
22. GAGAL
JANTUNG AKUT
Resusitasi segera
Distres atau nyeri
Diagnosis
definitif
Normal HR dan irama
Saturasi O2 >95%
MAP > 70
Naikkan FiO2,
CPAP,NIPPV
BCLS/ACLS
Preload
adekuat
Monitoring invasif, kateter
swan gans bila perlu
Tdk
Ya
tdk
ya
tdk
ya
ya
Algoritma
diagnosis
CO cukup : perbaiki asidosis
metabolik, SvO2 > 65%, tanda
klinis perfusi adekuat
tdk
ya
tdk
Pacing, anti
aritmia
tdk
ya
Analgesia/sedasi
Vasodilator,
pertimbangkan diuresis
bila volume overload
Fluid challenge
Inotropik/
Vasopresor /
IABP
Evaluasi
Tatalaksana
definitif
Algoritme Tatalaksana Cepat GJA
23. Goals ofMonitors
To assure the adequacy of perfusion
Early detection of inadequacy of perfusion
To titrate therapy to specific hemodynamic end point
To differentiate among various organ system
dysfunctions
Hemodynamic monitoringforindividualpatientshouldbe
physiologicallybasedand goal oriented
24.
25. Advance in haemodynamic assessment
• Modification of old equipment
• Echocardiogram and esophageal doppler
• Pulse contour analysis and transpulmonary thermodilution
• Partial carbon dioxide rebreathing with application of Fick
principle
• Electrical bioimpedance
26. Central Venous
Catheter
Injectate temperature
sensor housing
PULSIOCATH thermodilution catheter
Injectate temperature sensor cable
PULSION disposable pressure transducer
Temperature interface cable
Pressure cable
PiCCO2 Setup
30. Basic principles - Vasopressors
MAP = CO x SVR
CO = HR x SV
Preload Contractility Afterload
~ 1
r4
31. Basic principles - Inotropes
MAP = CO x SVR
CO = HR x SV
Preload Contractility Afterload
32. How to measure CO and SVR
Direct measurement
• Echo bed side
• Continuous Hemodynamic Monitoring (PiCCO,
Vigileo etc)
• Impedance Physioflow
SVR : MAP – CVP x 80
HR x SV
SV : VTI x CSA